XVIVO — Xvivo Perfusion AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK5.30bn
- SEK5.09bn
- SEK822.42m
Annual cashflow statement for Xvivo Perfusion AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -57.3 | 6.67 | 22.3 | 94.5 | 200 |
| Depreciation | |||||
| Non-Cash Items | 49.4 | 7.2 | -14.7 | -78.3 | -87 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.36 | -25.9 | -22 | -46.2 | -89.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.3 | -12.1 | 27.9 | 46.3 | 111 |
| Capital Expenditures | -64.7 | -94.1 | -131 | -144 | -193 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -202 | -93.6 | -66.7 | -17.7 | -50.7 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -267 | -188 | -198 | -162 | -244 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 483 | 235 | -6.84 | 419 | -10.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 194 | 44.5 | -152 | 300 | -131 |